Neuropsychological Assessment Battery-Screening Module (S-NAB): Performance in treatment-seeking cocaine users

References

• Sofuoglu M, Waters AJ, Poling J, Carroll KM. Galantamine improves sustained attention in chronic cocaine users. Exp Clin Psychopharmacol 2011;19:11–19
   PubMed Web of Science ®Google Scholar
• Carroll KM, Kiluk BD, Nich C, Babuscio TA, Brewer JA, Potenza MN, Ball SA, et al. Cognitive function and treatment response in a randomized clinical trial of computer-based training in cognitive-behavioral therapy. Subst Use Misuse 2011;46:23–34
   PubMed Web of Science ®Google Scholar
• Sofuoglu M, DeVito EE, Waters AJ, Carroll KM. Cognitive enhancement as a treatment for drug addictions. Neuropharmacology 2013;64:452–463
   PubMed Web of Science ®Google Scholar
• Jovanovski D, Erb S, Zakzanis KK. Neurocognitive deficits in cocaine users: a quantitative review of the evidence. J Clin Experim Neuropsychol 2005;27:189–204
   PubMed Web of Science ®Google Scholar
• Ardila A, Rosselli M, Strumwasser S. Neuropsychological deficits in chronic cocaine abusers. Int J Neurosci 1991;57:73–79
   PubMed Web of Science ®Google Scholar
• Cunha PJ, Nicastri S, Gomes LP, Moino RM, Peluso MA. Neuropsychological impairments in crack cocaine-dependent inpatients: preliminary findings. Rev Bras Psiquiatr 2004;26:103–106
   PubMedGoogle Scholar
• Aharonovich E, Nunes E, Hasin D. Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug Alcohol Depend 2003;71:207–211
   PubMed Web of Science ®Google Scholar
• Lorea I, Fernandez-Montalvo J, Tirapu-Ustarroz J, Landa N, Lopez-Goni JJ. [Neuropsychological performance in cocaine addiction: a critical review]. Revista de neurologia 2010;51:412–426
   PubMed Web of Science ®Google Scholar
• Madoz-Gurpide A, Blasco-Fontecilla H, Baca-Garcia E, Ochoa-Mangado E. Executive dysfunction in chronic cocaine users: an exploratory study. Drug Alcohol Depend 2011;117:55–58
   PubMed Web of Science ®Google Scholar
• Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A, Nunes EV. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend 2006;81:313–322
   PubMed Web of Science ®Google Scholar
• Berry J, van Gorp WG, Herzberg DS, Hinkin C, Boone K, Steinman L, Wilkins JN. Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence. Drug Alcohol Depend 1993;32:231–237
   PubMed Web of Science ®Google Scholar
• Horner MD. Cognitive functioning in alcoholic patients with and without cocaine dependence. Arch Clin Neuropsychol 1997;12:667–676
   PubMed Web of Science ®Google Scholar
• Turner TH, LaRowe S, Horner MD, Herron J, Malcolm R. Measures of cognitive functioning as predictors of treatment outcome for cocaine dependence. J Subst Abuse Treat 2009;37:328–334
   PubMed Web of Science ®Google Scholar
• Brewer JA, Worhunsky PD, Carroll KM, Rounsaville BJ, Potenza MN. Pretreatment brain activation during stroop task is associated with outcomes in cocaine-dependent patients. Biolog Psychiatry 2008;64:998–1004
   PubMed Web of Science ®Google Scholar
• Horton AM Jr, Roberts C. Sex, ethnicity, age and education effects on the Trail Making test in a sample of cocaine abusers. Int J Neurosci 2001;108:281–290
   PubMed Web of Science ®Google Scholar
• Verdejo-Garcia A, Betanzos-Espinosa P, Lozano OM, Vergara-Moragues E, Gonzalez-Saiz F, Fernandez-Calderon F, Bilbao-Acedos I, Perez-Garcia M. Self-regulation and treatment retention in cocaine dependent individuals: a longitudinal study. Drug Alcohol Depend 2012;122:142–148
   PubMed Web of Science ®Google Scholar
• Streeter CC, Terhune DB, Whitfield TH, Gruber S, Sarid-Segal O, Silveri MM, Tzilos G, et al. Performance on the Stroop predicts treatment compliance in cocaine-dependent individuals. Neuropsychopharmacology 2008;33:827–836
   PubMed Web of Science ®Google Scholar
• Teichner G, Horner MD, Roitzsch JC, Herron J, Thevos A. Substance abuse treatment outcomes for cognitively impaired and intact outpatients. Addict Behav 2002;27:751–763
   PubMed Web of Science ®Google Scholar
• Sahakian BJ, Owen AM. Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J R Soc Med 1992;85:399–402
   PubMed Web of Science ®Google Scholar
• Grant JE, Chamberlain SR, Schreiber L, Odlaug BL. Neuropsychological deficits associated with cannabis use in young adults. Drug Alcohol Depend 2012;121:159–162
   PubMed Web of Science ®Google Scholar
• Piechatzek M, Indlekofer F, Daamen M, Glasmacher C, Lieb R, Pfister H, Tucha O, et al. Is moderate substance use associated with altered executive functioning in a population-based sample of young adults? Human Psychopharmacol 2009;24:650–665
   PubMed Web of Science ®Google Scholar
• Maruff P, Burns CB, Tyler P, Currie BJ, Currie J. Neurological and cognitive abnormalities associated with chronic petrol sniffing. Brain 1998;121:1903–1917
   PubMed Web of Science ®Google Scholar
• Kopera M, Wojnar M, Brower K, Glass J, Nowosad I, Gmaj B, Szelenberger W. Cognitive functions in abstinent alcohol-dependent patients. Alcohol 2012;46:665–671
   PubMed Web of Science ®Google Scholar
• Powell DH, Kaplan EF, Whitla D, Catlin R, Funkenstein HH. MicroCog: assessment of cognitive functioning, Version 2.1. San Antonio, TX: The Psychological Corporation; 1993
   Google Scholar
• Acosta MC, Marsch LA, Xie H, Guarino H, Aponte-Melendez Y. A web-based behavior therapy program influences the association between cognitive functioning and retention and abstinence in clients receiving methadone maintenance treatment. J Dual Diagnosis 2012;8:283–293
   PubMed Web of Science ®Google Scholar
• Stern RA, White T. Neuropsychological Assessment Battery: administration, scoring, and interpretation manual. Lutz, FL: Psychological Assessment Resources; 2003
   Google Scholar
• Zgaljardic DJ, Temple RO. Neuropsychological Assessment Battery (NAB): performance in a sample of patients with moderate-to-severe traumatic brain injury. Appl Neuropsychol 2010;17:283–288
   PubMed Web of Science ®Google Scholar
• Zgaljardic DJ, Temple RO. Reliability and validity of the Neuropsychological Assessment Battery-Screening Module (NAB-SM) in a sample of patients with moderate-to-severe acquired brain injury. Appl Neuropsychol 2010;17:27–36
   PubMed Web of Science ®Google Scholar
• Zgaljardic DJ, Yancy S, Temple RO, Watford MF, Miller R. Ecological validity of the screening module and the Daily Living tests of the Neuropsychological Assessment Battery using the Mayo-Portland Adaptability Inventory-4 in postacute brain injury rehabilitation. Rehabil Psychol 2011;56:359–365
   PubMed Web of Science ®Google Scholar
• Temple RO, Zgaljardic DJ, Abreu BC, Seale GS, Ostir GV, Ottenbacher KJ. Ecological validity of the neuropsychological assessment battery screening module in post-acute brain injury rehabilitation. Brain Inj 2009;23:45–50
   PubMed Web of Science ®Google Scholar
• Lange RT, Iverson GL, Brooks BL, Rennison VL. Influence of poor effort on self-reported symptoms and neurocognitive test performance following mild traumatic brain injury. J Clin Exp Neuropsychol 2010;32:961–972
   PubMed Web of Science ®Google Scholar
• McLennan SN, Mathias JL, Brennan LC, Stewart S. Validity of the montreal cognitive assessment (MoCA) as a screening test for mild cognitive impairment (MCI) in a cardiovascular population. J Geriatr Psychiatry Neurol 2011;24:33–38
   PubMed Web of Science ®Google Scholar
• Grohman K, Fals-Stewart W. The detection of cognitive impairment among substance-abusing patients: the accuracy of the neuropsychological assessment battery-screening module. Exp Clin Psychopharmacol 2004;12:200–207
   PubMed Web of Science ®Google Scholar
• Copersino ML, Fals-Stewart W, Fitzmaurice G, Schretlen DJ, Sokoloff J, Weiss RD. Rapid cognitive screening of patients with substance use disorders. Exp Clin Psychopharmacol 2009;17:337–344
   PubMed Web of Science ®Google Scholar
• van Holst RJ, Schilt T. Drug-related decrease in neuropsychological functions of abstinent drug users. Current Drug Abuse Rev 2011;4:42–56
   PubMedGoogle Scholar
• Hasin DS, Trautman KD, Miele GM, Samet S, Smith M, Endicott J. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. Am J Psychiatry 1996;153:1195–1201
   PubMed Web of Science ®Google Scholar
• Hasin D, Samet S, Nunes E, Meydan J, Matseoane K, Waxman R. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am J Psychiatry 2006;163:689–696
   PubMed Web of Science ®Google Scholar
• Conners CK, Erhardt D, Sparrow E. Conners’ adult ADHD Rating scales (CAARS) technical manual. New York: Multi-Health Systems; 1999
   Google Scholar
• Dakwar E, Mahony A, Pavlicova M, Glass A, Brooks D, Mariani JJ, Grabowski J, Levin FR. The utility of attention-deficit/hyperactivity disorder screening instruments in individuals seeking treatment for substance use disorders. J Clin Psychiatry 2012;73:e1372–1378
   PubMed Web of Science ®Google Scholar
• Adler LA, Faraone SV, Spencer TJ, Michelson D, Reimherr FW, Glatt SJ, Marchant BK, Biederman J. The reliability and validity of self- and investigator ratings of ADHD in adults. J Attention Disorders 2008;11:711–719
   PubMed Web of Science ®Google Scholar
• Strauss E, Sherman EMS, Spreen O. A compendium of neuropsychological tests: administration, norms and commentary. New York, NY: Oxford University Press, Inc.; 2006
   Google Scholar
• Wechsler D. Wechsler Test of Adult Reading. San Antonio, TX: The Psychological Corporation (Harcourt Assessment); 2001
   Google Scholar
• SAS Institute Inc. SAS/STAT, Version 9.2. Cary, NC: SAS Institute Inc.; 2011
   Google Scholar
• Winsauer PJ, Moerschbaecher JM, Brauner IN, Purcell JE, Lancaster JR Jr, Bagby GJ, Nelson S. Alcohol unmasks simian immunodeficiency virus-induced cognitive impairments in rhesus monkeys. Alcoholism, Clin Experim Res 2002;26:1846–1857
   PubMed Web of Science ®Google Scholar
• Kim DH, Jewison DL, Milner GR, Rourke SB, Gill MJ, Power C. Neurocognitive symptoms and impairment in an HIV community clinic. Canadian J Neurolog Sci 2001;28:228–231
   PubMed Web of Science ®Google Scholar